These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18924018)

  • 1. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A; Hepp C; Harder H; Beglinger C; Singer MV
    Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
    Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
    Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
    Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
    Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
    Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole for the treatment of GERD in infants ages 1-11 months.
    Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):14-20. PubMed ID: 22241513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
    Reichel O; Dressel H; Wiederänders K; Issing WJ
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
    Tipnis NA; Rhee PL; Mittal RK
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G469-74. PubMed ID: 17556589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
    Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
    Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
    Kiljander TO; Junghard O; Beckman O; Lind T
    Am J Respir Crit Care Med; 2010 May; 181(10):1042-8. PubMed ID: 20110554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO; Koch FK; Ballard ED; Bagin RG; Gautille TC; Checani GC; Hogan DL; Pratha VS
    Aliment Pharmacol Ther; 2007 Jan; 25(2):197-205. PubMed ID: 17229243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.
    Faruqi S; Molyneux ID; Fathi H; Wright C; Thompson R; Morice AH
    Respirology; 2011 Oct; 16(7):1150-6. PubMed ID: 21707852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.
    Kiljander TO; Harding SM; Field SK; Stein MR; Nelson HS; Ekelund J; Illueca M; Beckman O; Sostek MB
    Am J Respir Crit Care Med; 2006 May; 173(10):1091-7. PubMed ID: 16357331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.